Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don’t

por van der Veen, Sanne Jolien, Langeveld, Mirjam
Publicado 2022

Developments in the treatment of Fabry disease

por van der Veen, Sanne J., Hollak, Carla E. M., van Kuilenburg, André B. P., Langeveld, Mirjam
Publicado 2020

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease

por van der Veen, Sanne J., Vlietstra, Wytze J., van Dussen, Laura, van Kuilenburg, André B.P., Dijkgraaf, Marcel G. W., Lenders, Malte, Brand, Eva, Wanner, Christoph, Hughes, Derralynn, Elliott, Perry M., Hollak, Carla E. M., Langeveld, Mirjam
Publicado 2020

Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation

por van Kuilenburg, André B. P., Hollak, Carla E. M., Travella, Ana, Jacobs, Melisa, Gentilini, Lucas D., Leen, René, der Vlugt, Karen M. M. Ghauharali-van, Stet, Femke S. Beers, Goorden, Susan M. I., van der Veen, Sanne, Criscuolo, Marcelo, Papouchado, Mariana
Publicado 2023